Dirk Zboralski
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Hematology top 10%
- Co-authors
- Dirk EulbergAnna KruschinskiChristian MaaschAxel VaterKai HoehligJan A. BurgerJulia HoellenriegelMichael J. Keating
- Topics
- Peptidase Inhibition and Analysis (6 papers)Radiopharmaceutical Chemistry and Applications (5 papers)Chemokine receptors and signaling (5 papers)
- Cited by
- OncologyHematologyImmunology
- Journals
- BloodCancer ResearchOncogene
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Dirk Zboralski
22 papers receiving 915 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 503
- Molecular Biology 332
- Immunology 218
- Radiology, Nuclear Medicine and Imaging 149
- Hematology 135
Countries citing papers authored by Dirk Zboralski
This map shows the geographic impact of Dirk Zboralski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Zboralski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Zboralski more than expected).
Fields of papers citing papers by Dirk Zboralski
This network shows the impact of papers produced by Dirk Zboralski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Zboralski. The network helps show where Dirk Zboralski may publish in the future.
Co-authorship network of co-authors of Dirk Zboralski
This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Zboralski. A scholar is included among the top collaborators of Dirk Zboralski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Zboralski. Dirk Zboralski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 27 | |
| 3 | 4 | |
| 4 | Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Resultsbreakdown → | 210 |
| 5 | 4 | |
| 6 | 14 | |
| 7 | Peptide-Targeted Radionuclide Therapy (PTRT) using Lu-177 FAP-2286 in Diverse Adenocarcinomas: Feasibility, Biodistribution and Preliminary Dosimetry in a First-in-human study | 4 |
| 8 | 3 | |
| 9 | 60 | |
| 10 | 135 | |
| 11 | 1 | |
| 12 | 20 | |
| 13 | 73 | |
| 14 | 179 | |
| 15 | 3 | |
| 16 | 2 | |
| 17 | 3 | |
| 18 | 12 | |
| 19 | 16 | |
| 20 | 29 |
About Dirk Zboralski
Dirk Zboralski is a scholar working on Oncology, Immunology and Allergy and Genetics, having authored 22 papers that have together received 937 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Chemokine receptors and signaling (5 papers). The work is most often cited by research in Oncology (503 citations), Hematology (135 citations) and Immunology (218 citations). Dirk Zboralski has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Dirk Eulberg, Anna Kruschinski, Christian Maasch, Axel Vater, Kai Hoehlig, Jan A. Burger, Julia Hoellenriegel, Michael J. Keating, William G. Wierda and Nathalie Y. Rosin. Their work appears in journals such as Blood, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.